{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:09:44Z","timestamp":1788548984621,"version":"build-2803163510"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dietary measures have been used as an adjunctive therapy in the management of psoriasis. Intermittent fasting (IF) is an eating pattern in which energy is not consumed for a fixed duration, resulting in metabolic switch from liver-derived glucose to adipose-derived ketones. The data regarding effectiveness of IF in psoriasis are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Objectives:<\/jats:title>\n                    <jats:p>The aim of this study was to assess efficacy of IF in patients with chronic plaque psoriasis. The primary outcome of the study was change in psoriasis severity as measured by psoriasis area and severity index (PASI) at 28 weeks. The secondary outcome measures were change in metabolic parameters and biomarkers for atherosclerosis in each group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>The study was designed as a randomized parallel group trial. Clinical parameters, psoriasis severity, fasting and postprandial blood sugar, lipid profile, high sensitivity C-reactive protein (hsCRP), vascular endothelial growth factor (VEGF), and interleukin 6 (IL-6), were measured using standard methods at baseline, 16 weeks, and 28 weeks. Patients were randomized to receive methotrexate in the dose of 0.3 mg\/Kg\/week with or without intermittent fasting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 120 patients were randomized in two groups of 60 each: group 1 (methotrexate) and group 2 (methotrexate and intermittent fasting). The mean age, mean duration of disease, PASI, and dermatology life quality index (DLQI) in group 1 were 45.5 (\u00b112.9) years, 5.06 (\u00b15.5) years, 17.1 (\u00b16.7), and 12.33 (\u00b15), respectively. The mean age, mean duration of disease, PASI, and DLQI in group 2 were and 42.9 (\u00b114.6) years, 6.91 (\u00b16.2) years, 16 (\u00b14.3), and 11.9 (\u00b14.3), respectively. There was no statistically significant difference in baseline parameters in two groups. In both the groups, there was a statistically significant difference in PASI, DLQI, VEGF, and hsCRP from baseline to 16 and 28 weeks. At week 16, 44 (73.3%) patients in group 1 and 47 (78.3%) in group 2 achieved PASI50 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.8). At week 28, 16 (36%) in group 1 and 27 (54.4%) patients in group 2 maintained PASI50 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.054). There was a statistically significant weight and waist circumference reduction at 16 weeks and 28 weeks in group 2. There was a statistically significant reduction in VEGF, IL6, and hsCRP at 28 weeks in group 2 as compared to group 1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>The small sample size and loss to follow-up are major limitations of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Intermittent fasting using 16: 8 protocol is easy to perform and a safe and effective adjuvant for managing severe chronic plaque psoriasis. It helps in maintaining remission and results in improvement in metabolic parameters and markers of vascular inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_635_24","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T05:00:09Z","timestamp":1744952409000},"page":"389-396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of Intermittent Fasting in the Management of Chronic Plaque Psoriasis: A Phase IIb Clinical Trial"],"prefix":"10.4103","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-1676","authenticated-orcid":false,"given":"Shekhar","family":"Neema","sequence":"first","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Vausdevan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Pathology, 151 Base Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senkadhir","family":"Vendhan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MK","family":"Sibin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, AFMC, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Patrikar","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, AFMC, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/2229-5178.193906","article-title":"Psoriasis:Epidemiology, clinical features, co-morbidities, and clinical scoring","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00011-017-1065-z","article-title":"\u201cInflammatory skin march\u201din atopic dermatitis and psoriasis","volume":"66","author":"Furue","year":"2017","journal-title":"Inflamm Res"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis:A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1194\/jlr.P020867","article-title":"The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men","volume":"53","author":"Browning","year":"2012","journal-title":"J Lipid Res"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting:Molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrn.2017.156","article-title":"Intermittent metabolic switching, neuroplasticity and brain health","volume":"19","author":"Mattson","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1038\/ncomms14063","article-title":"Caloric restriction improves health and survival of rhesus monkeys","volume":"8","author":"Mattison","year":"2017","journal-title":"Nat Commun"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.molmed.2014.05.001","article-title":"Caloric restriction and cancer:Molecular mechanisms and clinical implications","volume":"20","author":"Meynet","year":"2014","journal-title":"Trends Mol Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12967-016-1044-0","article-title":"Effects of eight weeks of time-restricted feeding (16\/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males","volume":"14","author":"Moro","year":"2016","journal-title":"J Transl Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.1035720100","article-title":"Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake","volume":"100","author":"Anson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"103408","DOI":"10.1016\/j.autrev.2023.103408","article-title":"Intermittent fasting:A promising dietary intervention for autoimmune diseases","volume":"22","author":"Barati","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/exd.14932","article-title":"A 2-week time-restricted feeding attenuates psoriasis-like lesions with reduced inflammatory cytokines and immunosenescence in mice","volume":"32","author":"Chen","year":"2023","journal-title":"Exp Dermatol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate-tosevere chronic plaque psoriasis to low-dose cyclosporine therapy:A randomized, controlled, investigator-blinded clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/nu11020277","article-title":"The impact of Ramadan fasting on the reduction of PASI score, in moderate-to-severe psoriatic patients:A real-life multicenter study","volume":"11","author":"Damiani","year":"2019","journal-title":"Nutrients"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5114\/ada.2021.107098","article-title":"Clinical implications of intermittent Ramadan fasting on stable plaque psoriasis:A prospective observational study","volume":"39","author":"Almutairi","year":"2022","journal-title":"Postepy Dermatol Alergol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/nu11030601","article-title":"The impact of intermittent fasting (Ramadan Fasting) on psoriatic arthritis disease activity, enthesitis, and dactylitis:A multicentre study","volume":"11","author":"Adawi","year":"2019","journal-title":"Nutrients"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"e26405","DOI":"10.2196\/26405","article-title":"The effects of modified intermittent fasting in psoriasis (MANGO):Protocol for a two-arm pilot randomized controlled open cross-over study","volume":"11","author":"Grine","year":"2022","journal-title":"JMIR Res Protoc"},{"key":"R20-20250503","first-page":"E22","article-title":"The effects of Modified Intermittent Fasting in Psoriasis (MANGO)\u202f:Preliminary results of a pilot crossover study","volume":"186","author":"Grine","year":"2022","journal-title":"Br J Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_635_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:03:09Z","timestamp":1787760189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_635_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_635_24","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"2024-06-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}